Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

hexamethylene bisacetamide

A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:hexamethylenebisacetamide
hexamethylenediacetamide
Abbreviation:HMBA
Chemical structure:acetamide, N,N'-1, 6-hexanediylbis-
acetamide, N,N'-hexamethylenebis-
N, N'-diacetylhexamethylenediamine
N,N'-1,6-hexanediylbisacetamide
N,N'-hexamethylenebisacetamide
IND number:24942
NSC code:95580
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search